The Recall Desk
LowFDA (Drugs)·D-0194-2025·Announced 2025-01-22

Acetaminophen tablets recalled for incorrect imprinting

Akron Pharma is recalling Acetaminophen Regular Strength 325 mg tablets due to incorrect imprinting on the tablets. The recall involves approximately 6,429 bottles distributed nationwide.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: FDA Class III recall for a labeling and identification issue with no reported illnesses or injuries, making this a low-risk precautionary recall.

Plain-English summary

Akron Pharma, Inc. is recalling Acetaminophen Regular Strength tablets, 325 mg, in bottles of 100 tablets. The tablets are imprinted with incorrect identification. The affected product is lot number KDT0124001 with an expiration date of August 31, 2026, NDC number 71399-8024-01.

Approximately 6,429 bottles were distributed nationwide throughout the United States. This is a Class III recall issued by the U.S. Food and Drug Administration.

The recalled product

Product
Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .
Manufacturer
Akron Pharma, Inc.
Category
Drug
Hazard
  • mis-labeling

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: KDT0124001
  • Exp 08/31/2026

Distribution

Distributed nationwide across the United States.

Related recalls

Same category